Search Results - "Paolo, Therese Di"
-
1
Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: An update from the last 5 years of research
Published in Neuropharmacology (15-03-2017)“…Disturbance of glutamate neurotransmission in Parkinson's disease (PD) and l-DOPA induced dyskinesia (LID) is well documented. This review focuses on advances…”
Get full text
Journal Article -
2
Raloxifene activates G protein-coupled estrogen receptor 1/Akt signaling to protect dopamine neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice
Published in Neurobiology of aging (01-10-2014)“…Abstract Raloxifene, used in the clinic, is reported to protect brain dopaminergic neurons in mice. Raloxifene was shown to mediate an effect through the G…”
Get full text
Journal Article -
3
Neuroprotective actions of sex steroids in Parkinson’s disease
Published in Frontiers in neuroendocrinology (01-07-2009)“…Abstract The sex difference in Parkinson’s disease, with a higher susceptibility in men, suggests a modulatory effect of sex steroids in the brain. Numerous…”
Get full text
Journal Article -
4
Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments
Published in Parkinson's disease (01-01-2016)“…A diagnosis of Parkinson’s disease is classically established after the manifestation of motor symptoms such as rigidity, bradykinesia, and tremor. However, a…”
Get full text
Journal Article -
5
Neuroprotective and immunomodulatory effects of raloxifene in the myenteric Plexus of a mouse model of Parkinson’s disease
Published in Neurobiology of aging (01-12-2016)“…Abstract Motor symptoms in Parkinson’s disease (PD) are often preceded by non-motor symptoms related to dysfunctions of the autonomic nervous system such as…”
Get full text
Journal Article -
6
Neuroprotection and immunomodulation of progesterone in the gut of a mouse model of Parkinson's disease
Published in Journal of neuroendocrinology (01-01-2020)“…Gastrointestinal symptoms appear in Parkinson's disease patients many years before motor symptoms, suggesting the implication of dopaminergic neurones of the…”
Get full text
Journal Article -
7
Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice
Published in PloS one (09-03-2016)“…Plasmalogens are a class of glycerophospholipids shown to play critical roles in membrane structure and function. Decreased plasmalogens are reported in the…”
Get full text
Journal Article -
8
The number of striatal cholinergic interneurons expressing calretinin is increased in parkinsonian monkeys
Published in Neurobiology of disease (01-11-2016)“…Abstract The most abundant interneurons in the primate striatum are those expressing the calcium-binding protein calretinin (CR). The present…”
Get full text
Journal Article -
9
Three-Dimensional Analysis of Sex- and Gonadal Status- Dependent Microglial Activation in a Mouse Model of Parkinson's Disease
Published in Pharmaceuticals (Basel, Switzerland) (20-01-2023)“…Parkinson's disease (PD) is characterized by neurodegeneration and neuroinflammation. PD prevalence and incidence are higher in men than in women and…”
Get full text
Journal Article -
10
Sex and Age Differences in a Progressive Synucleinopathy Mouse Model
Published in Biomolecules (Basel, Switzerland) (01-06-2023)“…The mutation and overexpression of the alpha-synuclein protein (αSyn), described as synucleinopathy, is associated with Parkinson's disease (PD)-like…”
Get full text
Journal Article -
11
GPER1-mediated immunomodulation and neuroprotection in the myenteric plexus of a mouse model of Parkinson's disease
Published in Neurobiology of disease (01-10-2015)“…Abstract Lewy pathology affects the gastrointestinal tract in Parkinson's disease (PD) and recent reports suggest a link between the disorder and gut…”
Get full text
Journal Article -
12
Implication of GPER1 in neuroprotection in a mouse model of Parkinson's disease
Published in Neurobiology of aging (01-03-2013)“…Abstract This study investigated the contribution of the new G protein-coupled estrogen receptor 1 (GPER1) in neuroprotection by 17β-estradiol in the…”
Get full text
Journal Article -
13
Evidence for Sprouting of Dopamine and Serotonin Axons in the Pallidum of Parkinsonian Monkeys
Published in Frontiers in neuroanatomy (15-05-2018)“…This light and electron microscopie immunohistochemical quantitative study aimed at determining the state of the dopamine (DA) and serotonin (5-HT)…”
Get full text
Journal Article -
14
Steroids‐Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders
Published in CNS neuroscience & therapeutics (01-06-2010)“…SUMMARY Introduction: Dopamine cell loss is well documented in Parkinson's disease and dopamine hypofunction is proposed in certain depressive states. At the…”
Get full text
Journal Article -
15
Neuroprotective Effect of Progesterone in MPTP-Treated Male Mice
Published in Neuroendocrinology (01-01-2016)“…Numerous studies have reported on the neuroprotective activity of estradiol, whereas the effect of the other ovarian steroid, progesterone, is much less…”
Get more information
Journal Article -
16
Long-term treatment with l-DOPA and an mGlu5 receptor antagonist prevents changes in brain basal ganglia dopamine receptors, their associated signaling proteins and neuropeptides in parkinsonian monkeys
Published in Neuropharmacology (01-04-2014)“…Brain glutamate overactivity is well documented in Parkinson's disease (PD) and antiglutamatergic drugs decrease L-3,4-dihydroxyphenylalanine (l-DOPA)-induced…”
Get full text
Journal Article -
17
Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson's Disease Models
Published in Frontiers in pharmacology (22-07-2022)“…Gastrointestinal disorders in Parkinson's disease (PD) have been associated with neuronal alteration in the plexus of the gut. We previously demonstrated the…”
Get full text
Journal Article -
18
Metabotropic Glutamate Receptors for Parkinson's Disease Therapy
Published in Parkinson's disease (01-01-2013)“…Excessive glutamatergic signalling within the basal ganglia is implicated in the progression of Parkinson’s disease (PD) and inthe emergence of dyskinesia…”
Get full text
Journal Article -
19
Prevention of L-Dopa-Induced Dyskinesias by MPEP Blockade of Metabotropic Glutamate Receptor 5 Is Associated with Reduced Inflammation in the Brain of Parkinsonian Monkeys
Published in Cells (Basel, Switzerland) (16-02-2022)“…Proinflammatory markers were found in brains of Parkinson's disease (PD) patients. After years of L-Dopa symptomatic treatment, most PD patients develop…”
Get full text
Journal Article -
20
Sex differences in methamphetamine toxicity in mice: Effect on brain dopamine signaling pathways
Published in Psychoneuroendocrinology (01-08-2011)“…Summary Male mice were reported to display greater methamphetamine-induced neurotoxicity than females. The present study evaluated the involvement of…”
Get full text
Journal Article